Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-25-002979
Filing Date
2025-02-20
Accepted
2025-02-20 08:21:08
Documents
3
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6258
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 13114
3 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 7259
  Complete submission text file 0001062993-25-002979.txt   30594
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 25643388
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)